Definition of an extended MHC class II-peptide binding motif for the autoimmune disease-associated Lewis rat RT1.B(L) molecule

International Immunology

Volumn 9, Issue 2, 1997, Pages 281-290

  Wauben, Marca H M ^a   Van Der Kraan, Manou ^a   Grosfeld Stulemeyer, Mayken C ^a   Joosten, Irma ^b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Peptide analogs; Search profile; T cell epitope

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; T LYMPHOCYTE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; COMPLEX FORMATION; GUINEA PIG; IMMUNOTHERAPY; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; RAT; T LYMPHOCYTE;

AMINO ACID SEQUENCE; ANIMALS; AUTOIMMUNE DISEASES; BACTERIAL PROTEINS; BINDING SITES; CHAPERONINS; EPITOPES, T-LYMPHOCYTE; HISTOCOMPATIBILITY ANTIGENS; HISTOCOMPATIBILITY ANTIGENS CLASS II; MOLECULAR SEQUENCE DATA; MYELIN BASIC PROTEINS; PEPTIDES; PROTEIN BINDING; RATS; RATS, INBRED LEW; SEQUENCE ALIGNMENT;

EID: 0031058161     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/9.2.281     Document Type: Article

References (52)

1. Chou, Y. K., Vandenbark, A. A., Jones, R., Hashim, G. and Offner, H. 1989. Selection of encephalitogenic rat T lymphocyte clones recognizing an immunodominant epitope on myelin basic protein. J. Neurosci. Res. 22:181.
2. Offner, H., Hashim, G. A., Celnik, B., Glang, A., Li, X., Burns, F. R., Shen, N., Heber-Katz, E. and Vandenbark, A. A. 1989. T cell determinants of myelin basic protein include a unique encephalitogenic I-E restricted epitope for Lewis rats. J. Exp. Med. 170:355.
3. Sanui, H., Redmond, T. M., Kotake, S., Wiggert, B., Hu, L., Margalit, H., Berzofsky, J. A., Chader, G. J. and Gery, I. 1989. Identification of an immunodominant and highly immunopathogenic determinant in the retinal interphotoreceptor retinoid-binding protein (IRBP). J. Exp. Med. 169:1947.
4. Zhang, Y., Barkas, T., Juillerat, M., Schwendimann, B. and Wekerle, H. 1988. T cell epitopes in experimental autoimmune myasthenia gravis of the rat: strain specific epitopes and cross reaction between two distinct segments of the α chain of the nicotinic acetylcholine receptor. Eur. J. Immunol. 18:551.
5. Wegmann, K. W., Zhao, W., Griffin, A. C. and Hickey, W. F. 1994. Identification of myocarditogenic peptides derived from cardiac myosin capable of inducing experimental allergic myocarditis in the Lewis rat. J. Immunol. 153:892.
6. Zhao, W., Wegmann, K. W., Trotter, J. L., Ueno, K. and Hickey, W. F. 1994. Identification of an N-terminally acetylated encephalitogenic epitope in myelin proteolipid apoprotein for the Lewis rat. J. Immunol. 153:901.
7. Rostami, A. and Gregorian, S. K. 1991. Peptide 53-78 of myelin P2 protein is a T cell epitope for the induction of experimental autoimmune neuritis. Cell. Immunol. 132:433.
8. Kojirna, K., Berger, T., Lassmann, H., Hinze-Selch, D., Zhang, Y., Gehrmann, J., Reske, K., Wekerle, H. and Linington, C. 1994. Experimental autoimmune panencephalitis and uveoretinitis transferred to the Lewis rat by T lymphocytes specific for the S100β molecule, a calcium binding protein of astroglia. J. Exp. Med. 180:817.
9. Kotake, S., Sasamoto, Y., Kawano, Y. I., Sanui, H., Wiggert, B., Chader, G. J. and Gery, I. 1992. The existence of two completely distinct antigenic sites within a decapeptide. Cell, Immunol. 140:123.
10. Van Eden, W., Thole, J. E. R., van der Zee, R., Noordzij, A., van Embden, J. D. A., Hensen, E. J. and Cohen, I. R. 1988. Cloning of the mycobacterial epitope recognized by T lymphocytes in adjuvant arthritis. Nature 331:171.
11. Schwartz, R. H. 1985. T-lymphocyte recognition of antigen in association with gene products of the major histocompatibility complex. Annu. Rev. Immunol. 3:237.
12. Germain, R. N. and Margulies, D. H. 1993. The biochemistry and cell biology of antigen processing and presentation. Annu. Rev. Immunol. 11:403.
13. Rudensky, A. Y., Preston-Huriburt, P., Hong, S. C., Barlow, A. and Janeway, C. A. 1991. Sequence analysis of peptides bound to MHC class II molecules. Nature 353:622.
14. Rudensky, A. Y., Preston-Burlhurt, P., AI-Ramadi, B. K., Rothbard, J. and Janeway, C. A. 1992. Truncation variants of peptides isolated from MHC class II molecules suggest sequence motifs. Nature 359:429.
15. d. Science 256:1817.
16. Chicz, R. M., Urban, R. G., Lane, W. S., Gorga, J, C., Stern, L. J., Vignali, D. A. A. and Strominger, J. L. 1992. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size. Nature 358:764
17. Brown, J. H., Jardetzky, T. S., Gorga, J. C., Stern, L. J., Urban, R. G., Strominger, J. L. and Wiley, D. C. 1993. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 364:33.
18. Stern, L. J., Brown, J. H., Jardetzky, T. S., Gorga, J. C., Urban, R. G., Strominger, J. L. and Wiley, D. C. 1994. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 368:215.
19. Malcherek, G., Falk, K., Rötzschke, O., Rammensee, H.-G., Stevanovic, S., Gnau, V, Jung, G. and Melms, A. 1993. Natural peptide ligand motifs of two HLA molecules associated with myasthenia gravis. Int. Immunol. 5:1229.
20. Chicz, R. M., Urban, R. G., Gorga, J. C., Vignali, D. A. A., Lane, W. S. and Strominger, J. L. 1993. Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J. Exp. Med. 178:27.
21. Verreck, F. A. W., van de Poel, A., Termijtelen, A., Amons, R., Drijfhout, J.-W. and Koning, F. 1994. Identification of an HLA-DPw3-bound self-peptide by pool sequencing Eur J. Immunol. 24:375.
22. Marrack, P., Ignatowicz, L., Kappler, J. W., Boymel, J. and Freed, J. H. 1993. Comparison of peptides bound to spleen and thymus class II. J. Exp. Med. 178:2173.
23. Schild, H., Gruneberg, U., Pougialis, G., Wallny, H.-J, Keilholz, W., Stevanovic, S. and Rammensee, H.-G. 1995. Natural ligand motifs of H-2E molecules are allele specific and illustrate homology to HLA-DR molecules. Int. Immunol. 7:1957.
24. d-binding peptides derived from unrelated protein antigens share a common structural motif. J. Immunol. 141:45.
25. d molecules. J. Immunol. 143:3289.
26. Sette, A., Buus, S., Colon, S., Miles, C. and Grey, H. M. 1989. Structural analysis of peptides capable of binding to more than one Ia antigen. J. Immunol. 142:35.
27. Jardetzky, T. S., Gorga, J. C., Busch, R., Rothbard, J., Strominger, J. L. and Wiley, D. C. 1990. Peptide binding to HLA-DR1: a peptide with most residues substituted to alanine retains MHC binding. EMBO J. 9:1797.
28. d molecules in the activation of MHC class II-restricted T cells. J. Immunol. 147:198.
29. 1 allsles. J. Immunol, 149:2634.
30. Geluk, A., van Meijgaarden, K. E., Janson, A. A. M., Drijfhout, J. W., Meloen, R. H., de Vries, R. R. P. and Ottenhoff, T. H. M. 1992. Functional analysis of DR17(DR3)-restricted mycobacterial T cell epitopes reveals DR17-binding motif and enables the design of allele-specific competitor peptides. J. Immunol. 149:2864.
31. Sette, A., Sidney, J., Oseroff, C., del Guercio, M.-F., Southwood, S., Arrhenius, T., Powell, M. F., Colon, S. M., Gaeta, F. C. A. and Grey, H. M. 1993. HLA DR4w4-binding motifs illustrate the biochemical basis of degeneracy and specificity in peptide-DR interactions, J. Immunol. 151:3163.
32. Reay, P. A., Kantor, R. M. and Davis, M. M. 1994. Use of global amino acid replacements to define the requirements for MHC binding and T cell recognition of moth cytochrome c (93-103). J. Immunol. 152:3946.
33. Hammer, J., Takacs, B. and Sinigaglia, F. 1992. Identification of a motif for HLA-DR1 binding peptides using M13 display libraries. J. Exp. Med. 176:1007.
34. Hammer, J., Valsasnini, P., Tolba, K., Bolin, D., Higelin, J., Takacs, B. and Sinigaglia, F. 1993. Promiscuous and allelespecific anchors in HLA-DR-binding peptides. Cell 74:197.
35. Sakai, K., Zamvil, S. S., Mitchell, D, J., Hodgkinson, S., Rothbard, J. B. and Steinman, L. 1989. Prevention of experimental encephalomyelitis with peptides that block interaction of T cells with major histocompatibility complex proteins. Proc Natl Acad. Sci. USA 86:9470.
36. Srnilek, D. E., Wraith, D. C., Hodgkinson, S., Dwivedy, S., Steinman, L. and McDevitt, H. O. 1991. A single amino acid change in a myelin basic protein peptide confers the capacity to prevent rather than induce experimental autoimmune encephalomyelitis. Proc. Natl Acad. Sci. USA 88:9633.
37. Wauben, M. H. M., Boog, C. P. J., van der Zee, R., Joosten, I., Schlief, A. and van Eden, W. 1992. Disease inhibition by MHC binding peptide analogues of disease-associated epitopes: more than blocking alone. J. Exp. Med. 176:667.
38. De Magistris, M. T., Alexander, J., Coggeshall, M., Altman, A., Gaeta, F. C. A., Grey, H. M. and Sette, A. 1992. Antigen analogmajor histocompatibility complexes act as antagonists of the T cell receptor. Cell 68:625.
39. Evavold, B. D. and Allen, P. M. 1991. Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand. Science 252:1308.
40. Sette, A., Alexander, J., Ruppert, J., Snoke, K., Franco, A., Ishioka, G. and Grey, H. M. 1994. Antigen analogs/MHC complexes as specific T cell receptor antagonists. Annu. Rev. Immunol. 12:413.
41. Sloan-Lancaster, J., Evavold, B. D. and Allen, P M. 1994. Th2 cell clonal anergy as a consequence of partial activation. J. Exp. Med. 180:1195.
42. Gill, T. J., Kunz, H. W., Misra, D. N. and Cortese Hassett, A. L. 1987. The major histocompatibility complex of the rat. Transplantation 43:773.
43. Diamond, A. G., Hood, L. E., Howard, J. C., Windle, M. and Winoto, A. 1989. The class II genes of the rat MHC. J. Immunol. 142:3268.
44. Joosten, I., Wauben, M. H. M., Holewijn, M. C., Reske, K., Pedersen, L. O., Roosenboom, C. F. P., Hensen, E. J., van Eden, W. and Buus, S. 1994. Direct binding of autoimmune disease related epitopes to purified Lewis rat MHC class II molecules. Int. Immunol. 6:751.
45. Van der Zee, R., Anderton, S. M., Buskens, C. A. F., Alonso de Velasco, E. and van Eden, W. 1995. Heat-shock protein T cell epitopes as immunogenic carriers in subunit vaccines. In Maya, H. L. S., ed., Peptides 1994, p. 841. Proceedings of the 23rd European Peptide symposium, Escom, Leiden.
46. Serra, H. M., Crimi, C., Sette, A. and Cells, E. 1993. Fine restriction analysis and inhibition of antigen recognition in HLA-DQ-restricted T cells by major histocompatibility complex blockers and T cell receptor antagonists. Eur. J. Immunol. 23:2967.
47. Boots, A. M. H., Kusters, J. G., van Noort, J. M., Zwaagstra, K. A., Rijke, E., van der Zeijst, B. A. M. and Hensen, E. J. 1991. Localization of a T cell epitope within the nucleocapsid protein of avian coronavirus. Immunology 74:8.
48. Steward, J. M. and Young, J. D. 1984. Solid Phase Peptide Synthesis. Pierce Chemical, Rockford, IL.
49. Wauben, M. H. M., van der Zee, R., Joosten, I., Boog, C. P. J., van Dijk, A. M. C., Holewijn, M. C., Meloen, R. H. and van Eden, W. 1993. A peptide variant of an arthritis related T cell epitope induces T cells that recognize this peptide as a synthetic peptide but not in its naturally processed form. J. Immunol. 150:5722.
50. Falk, K., Rotzschke, O., Stevanovic, S., Jung, G. and Rammensee, H.-G. 1994. Pool sequencing of natural HLA-DR, DQ, and DP ligands reveals detailed peptide motifs, constraints of processing, and general rules, Immunogenetics 39:230.
51. Rammensee, H-G., Friede, T. and Stevanovic, S. 1995. MHC ligands and peptide motifs: first listing, Immunogenetics 41:178.
52. Kinouchi, R., Kobayasi, H., Sato, K., Kimura, S. and Katagiri, M. 1994. Peptide motifs of HLA-DR4/DR53 (DRB1*0405/DRB4*0101) molecules, Immunogenetics 40:376.